Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

German Study Hints Diabetes Drug Cuts Alzheimer's Risk

A large German study is the latest clinical trial to suggest that a cheap generic treatment for diabetes can stave off symptoms of Alzheimer's disease, although conclusive proof from a more formal trial could be about five years away. Earlier studies have suggested that people and animals given the widely used pill for type-2 diabetes, called pioglitazone, were less likely to develop Alzheimer's or other forms of dementia. The medicine is sold under the brand name Actos by...


Read complete article

© Voice of America -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter